EUVIMEDEUVIMED entdecken
Crossref

DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity

Yao Li iD, Jiongliang Wang iD, Linfu Zhou iD, Wenbin Gu iD, Le Qin, Dongdong Peng iD, Shanglin Li, Diwei Zheng, Qiting Wu, Youguo Long, Yao Yao, Shouheng Lin iD und 6 weitere

Science Immunology · 21.03.2025 · 10 (105)

DOI: 10.1126/sciimmunol.adm8251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 21.03.2025. Verfasst von Yao Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: China-New Zealand Joint Laboratory on Biomedicine and Health, National Key Laboratory of Immune Response and Immunotherapy, Guangdong Provincial Key …. Hauptthemen laut MEDLINE: DNA (Cytosine-5-)-Methyltransferase 1, Killer Cells, Natural, T-Lymphocytes, Cellular Reprogramming. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inactivation of the transcription factor BCL11B reprograms T cells into induced-T-to-NK cells (ITNKs). However, it remains unclear how BCL11B suppresses natural killer (NK) cell transcriptional programs. Here, we identified that the DNA methyltransferase DNMT1 physically interacts with BCL11B, increasing BCL11B stability and the fidelity of DNA methylation maintenance for NK cell–related genes, thereby repressing their expression. Moreover, DNMT1 maintains the epigenetic silencing of a distinct subset of NK cell–related genes independent of BCL11B. DNMT1 inhibition or depletion reprograms T cells and chimeric antigen receptor (CAR)–T cells into NK-like cells that exhibit more robust antitumor effects than BCL11B-deficient ITNKs and parental CAR-T cells. Moreover, H3K27me3 (trimethylation of histone 3 lysine 27) synergizes with DNA methylation to repress NK cell–related pathways, and combined EZH2 (enhancer of zeste homolog 2) and DNMT1 inhibition potentiates both the reprogramming and cytotoxicity of NK-like cells. Our findings uncover the molecular mechanisms that safeguard T cell identity and provide a rationale for deriving NK-like cells with epigenetic inhibitors for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA (Cytosine-5-)-Methyltransferase 1Killer Cells, NaturalT-LymphocytesCellular ReprogrammingHumansAnimalsMiceDNA MethylationRepressor Proteins

Substanzen

DNA (Cytosine-5-)-Methyltransferase 1DNMT1 protein, humanRepressor ProteinsDnmt1 protein, mouse

Autor:innen und Institutionen

  • China-New Zealand Joint Laboratory on Biomedicine and Health, National Key Laboratory of Immune Response and Immunotherapy, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, GIBH-HKU Guangdong-…
  • University of Chinese Academy of Sciences, Beijing, China.
  • Guangdong Zhaotai Cell Bioscience Ltd., Shunde, China.
  • Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China.
  • School of Biomedical Sciences, Stem Cell and Regenerative Medicine Consortium, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.
  • Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong SAR, China.

ORCID-Profile: Yao Li, Jiongliang Wang, Linfu Zhou, Wenbin Gu, Dongdong Peng, Shouheng Lin, Xiaofei Zhang, Jie Wang, Pentao Liu, Xiangqian Kong, Peng Li

Zitieren

APA

Li, Y., Wang, J., Zhou, L., Gu, W., Qin, L., Peng, D., Li, S., Zheng, D., Wu, Q., Long, Y., Yao, Y., Lin, S., Sun, M., Zhang, X., Wang, J., Liu, P., Kong, X., & Li, P. (2025). DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity. Science Immunology, 10(105). https://doi.org/10.1126/sciimmunol.adm8251

Vancouver

Li Y, Wang J, Zhou L, Gu W, Qin L, Peng D, et al. DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity. Science Immunology. 2025;10(105). doi:10.1126/sciimmunol.adm8251

BibTeX
@article{Li2025,
  author = {Li, Yao and Wang, Jiongliang and Zhou, Linfu and Gu, Wenbin and Qin, Le and Peng, Dongdong and Li, Shanglin and Zheng, Diwei and Wu, Qiting and Long, Youguo and Yao, Yao and Lin, Shouheng and Sun, Mingwei and Zhang, Xiaofei and Wang, Jie and Liu, Pentao and Kong, Xiangqian and Li, Peng},
  title = {DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity},
  journal = {Science Immunology},
  year = {2025},
  volume = {10},
  number = {105},
  doi = {10.1126/sciimmunol.adm8251}
}
Kostenlos starten →